Back to MW MARSHALL WACE, LLP

SRPTSRPT
25 quarters

Position history for MWMARSHALL WACE, LLP's holdings in SAREPTA THERAPEUTICS INC

MARSHALL WACE, LLP holds 2.2M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $39.6M as of 2026-Q2. The position was increased (+204.3% shares). SRPT represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$39.6M

Current Shares

2.2M

Total Value Change

+$38.5M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+204.3%
$39.6M0.0%$17.97
47
2026-Q1
Increased
725,068
+405.3%
$15.8M0.0%$15.87
45
2025-Q4
Increased
143,493
+36.5%
$3.1M0.0%$21.49
34
2025-Q3
New
105,113
-
$2M0.0%$18.82
36
2025-Q2
Exited
0
-100.0%
$00.0%$17.11
0
2025-Q1
New
27,197
-
$1.7M0.0%$70.41
36
2024-Q4
Exited
0
-100.0%
$00.0%$121.19
0
2024-Q3
Decreased
42,938
-0.9%
$5.4M0.0%$124.53
0
2024-Q2
Increased
43,335
+1196.3%
$6.8M0.0%$158.00
44
2024-Q1
New
3,343
-
$432,7850.0%$129.46
33
2023-Q4
Exited
0
-100.0%
$00.0%$96.43
0
2023-Q3
Increased
245,928
+316.5%
$29.8M0.1%$121.22
46
2023-Q2
Decreased
59,042
-67.1%
$6.8M0.0%$112.24
0
2023-Q1
Decreased
179,259
-3.6%
$24.7M0.1%$136.03
0
2022-Q4
New
186,005
-
$24.1M0.1%$129.58
40
2022-Q1
Exited
0
-100.0%
$00.0%$78.59
0
2021-Q4
Increased
503,638
+149x
$45.4M0.1%$90.59
47
2021-Q3
Decreased
3,349
-82.8%
$310,0000.0%$88.77
0
2021-Q2
Decreased
19,519
-15.6%
$1.5M0.0%$78.82
0
2021-Q1
New
23,136
-
$1.7M0.0%$73.10
36
2019-Q4
Exited
0
-100.0%
$00.0%$128.79
0
2019-Q3
New
24,153
-
$1.8M0.0%$75.00
36
2019-Q2
Exited
0
-100.0%
$00.0%$151.95
0
2019-Q1
Increased
11,934
+14.7%
$1.4M0.0%$119.19
29
2018-Q4
New
10,406
-
$1.1M0.0%$107.86
35

Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used